2019
DOI: 10.1055/a-0825-6487
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Artemisia Aucheri.L and Bupivacaine Encapsulated Nanoparticles on Nociceptive Pain

Abstract: Aim The purpose of this study was to evaluate the antinociceptive interaction between bupivacaine and Artemisia aucheri. L encapsulated nanoparticles. Methods and materials The effect of bupivacaine and Artemisia aucheri.L alone, and their encapsulated co-administration was assessed using the 3% formalin test in rat. Increasing doses of bupivacaine (31.6, 100, 178, and 316 mg/kg) or Artemisia aucheri.L (5.6, 10, 17.8, and 31.6 mg/kg) were given i.p. 10 min before 3% formalin administration. Results The possibl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(10 citation statements)
references
References 22 publications
0
10
0
Order By: Relevance
“…Bupivacaine has positive results in longer operative contexts (more than 40 minutes in duration) and with a lower association of analgesics. This is because bupivacaine prevented peripheral nerve sensitization, resulting in postoperative pain reduction [24]. Furthermore, the literature describes that prescribing bupivacaine is safe to attempt to alleviate chronic pain from AIP [25,26].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Bupivacaine has positive results in longer operative contexts (more than 40 minutes in duration) and with a lower association of analgesics. This is because bupivacaine prevented peripheral nerve sensitization, resulting in postoperative pain reduction [24]. Furthermore, the literature describes that prescribing bupivacaine is safe to attempt to alleviate chronic pain from AIP [25,26].…”
Section: Discussionmentioning
confidence: 99%
“…However, studies have shown that bupivacaine is not efficient in reducing short-term pain [27]. Furthermore, there is no evidence capable of demonstrating the efficacy of the routine use of bupivacaine or any advantage of this drug when compared to other local anesthetics [23,24].…”
Section: Discussionmentioning
confidence: 99%
“…The most developed and studied formulations are nanoemulsions [ 9 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ], followed by liposomes [ 10 , 24 , 25 , 26 , 27 ], and, finally, nanoparticles [ 11 , 28 , 29 , 30 , 31 , 32 , 33 , 34 ]. In general, the papers have similar developments: characterization of the formulation through tests that measure particle size, PDI, and zeta potential.…”
Section: Literature Searchmentioning
confidence: 99%
“…In general, the papers have similar developments: characterization of the formulation through tests that measure particle size, PDI, and zeta potential. Electron microscopy also uses physicochemical characterization, although not in all studies [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 25 , 27 , 33 ]. Some papers did not develop stability studies of the formulations developed, which is an important parameter during the product development process.…”
Section: Literature Searchmentioning
confidence: 99%
See 1 more Smart Citation